Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Crystal structures and properties of two hydrated conglomerate forms of the heart-rate-lowering agent ivabradine hydrochloride.

Zhou XB, Zhu JR, Liu JY, Jin ZP, Tang FY, Hu XR.

Acta Crystallogr C Struct Chem. 2019 May 1;75(Pt 5):545-553. doi: 10.1107/S2053229619004819. Epub 2019 Apr 11.

PMID:
31062711
2.

The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Dai W, Gao X, Xiao D, Li YL, Zhou XB, Yong Z, Su RB.

Front Pharmacol. 2019 Feb 19;10:105. doi: 10.3389/fphar.2019.00105. eCollection 2019.

3.

A new polymorph of the gastrokinetic drug cisapride monohydrate.

Zhou XB, Zhu JR, Gu JM, Hu XR.

Acta Crystallogr C Struct Chem. 2018 Jun 1;74(Pt 6):690-695. doi: 10.1107/S2053229618006836. Epub 2018 May 22.

PMID:
29870004
4.

A brain-targeted ampakine compound protects against opioid-induced respiratory depression.

Dai W, Xiao D, Gao X, Zhou XB, Fang TY, Yong Z, Su RB.

Eur J Pharmacol. 2017 Aug 15;809:122-129. doi: 10.1016/j.ejphar.2017.05.025. Epub 2017 May 11.

PMID:
28502631
5.

[Crystal structure and crystal form stability of trelagliptin succinate].

Ye JL, Zhou XB, Wu SX, Sun MY, Gu JM, Hu XR.

Yao Xue Xue Bao. 2016 Nov;51(11):1759-64. Chinese.

PMID:
29908134
6.

Design, Synthesis and Biological Evaluation of Brain-Targeted Thiamine Disulfide Prodrugs of Ampakine Compound LCX001.

Xiao D, Meng FH, Dai W, Yong Z, Liu JQ, Zhou XB, Li S.

Molecules. 2016 Apr 14;21(4):488. doi: 10.3390/molecules21040488.

7.

Effects of poly (ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur mustard-induced cutaneous injuries in vitro and in vivo.

Liu F, Jiang N, Xiao ZY, Cheng JP, Mei YZ, Zheng P, Wang L, Zhang XR, Zhou XB, Zhou WX, Zhang YX.

PeerJ. 2016 Apr 4;4:e1890. doi: 10.7717/peerj.1890. eCollection 2016.

8.

Comparison of the crystal structures of the potent anticancer and anti-angiogenic agent regorafenib and its monohydrate.

Sun MY, Wu SX, Zhou XB, Gu JM, Hu XR.

Acta Crystallogr C Struct Chem. 2016 Apr;72(Pt 4):291-6. doi: 10.1107/S2053229616003727. Epub 2016 Mar 10.

PMID:
27045179
9.

Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase.

Wei Z, Liu YQ, Wang YA, Li WH, Zhou XB, Zhao J, Huang CQ, Li XZ, Liu J, Zheng ZB, Li S.

Toxicol Lett. 2016 Mar 30;246:1-6. doi: 10.1016/j.toxlet.2016.01.015. Epub 2016 Jan 22.

PMID:
26809136
10.

Crystal structures of vortioxetine and its methanol monosolvate.

Zhou XB, Gu JM, Sun MY, Hu XR, Wu SX.

Acta Crystallogr E Crystallogr Commun. 2015 Jul 4;71(Pt 8):883-5. doi: 10.1107/S2056989015012256. eCollection 2015 Aug 1.

11.

New efficient imidazolium aldoxime reactivators for nerve agent-inhibited acetylcholinesterase.

Wei Z, Liu YQ, Zhou XB, Luo Y, Huang CQ, Wang YA, Zheng ZB, Li S.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5743-5748. doi: 10.1016/j.bmcl.2014.10.055. Epub 2014 Oct 22.

PMID:
25453812
12.

Synthesis and biological evaluation of substituted 4-(thiophen-2-ylmethyl)-2H-phthalazin-1-ones as potent PARP-1 inhibitors.

Wang LX, Zhou XB, Xiao ML, Jiang N, Liu F, Zhou WX, Wang XK, Zheng ZB, Li S.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3739-43. doi: 10.1016/j.bmcl.2014.07.001. Epub 2014 Jul 5.

PMID:
25086680
13.

Novel cross-link breaker based on zwitterion structure: synthesis, structure and druggability studies.

Cao S, Zhou XB, Zhang H, Li S, Zhong W.

Eur J Med Chem. 2013 Oct;68:89-95. doi: 10.1016/j.ejmech.2013.07.033. Epub 2013 Aug 9.

14.

Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides.

Lv K, Wang LL, Liu ML, Zhou XB, Fan SY, Liu HY, Zheng ZB, Li S.

Bioorg Med Chem Lett. 2011 May 15;21(10):3062-5. doi: 10.1016/j.bmcl.2011.03.031. Epub 2011 Mar 16.

PMID:
21450463
15.

Combination of fenofibrate and rosiglitazone synergistically ameliorate dyslipidemia and insulin resistance in mice with MSG metabolic syndrome.

Chen W, Zhang LH, Liu HY, Zhou XB, Wang LL.

Yao Xue Xue Bao. 2010 Nov;45(11):1459-66. No abstract available.

PMID:
21355528
16.

P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.

Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S.

Br J Pharmacol. 2009 Jul;157(5):724-35. doi: 10.1111/j.1476-5381.2009.00231.x. Epub 2009 May 5.

17.

Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.

Fan SY, Zheng ZB, Mi CL, Zhou XB, Yan H, Gong ZH, Li S.

Bioorg Med Chem. 2009 Jan 15;17(2):621-4. doi: 10.1016/j.bmc.2008.11.061. Epub 2008 Dec 3.

PMID:
19091578

Supplemental Content

Loading ...
Support Center